Suchita Pakkala

1.3k total citations
32 papers, 973 citations indexed

About

Suchita Pakkala is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Suchita Pakkala has authored 32 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Suchita Pakkala's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Suchita Pakkala is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Suchita Pakkala collaborates with scholars based in United States, Lebanon and Italy. Suchita Pakkala's co-authors include Suresh S. Ramalingam, Taofeek K. Owonikoko, Fadlo R. Khuri, Rathi N. Pillai, Madhusmita Behera, Chandra P. Belani, Alice O. Kamphorst, Rafi Ahmed, Conor Steuer and Nabil F. Saba and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Suchita Pakkala

32 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suchita Pakkala United States 15 685 522 154 120 106 32 973
Reyes Bernabé Spain 19 684 1.0× 611 1.2× 211 1.4× 102 0.8× 89 0.8× 92 1.1k
Filippo Gustavo Dall’Olio Italy 13 610 0.9× 433 0.8× 178 1.2× 136 1.1× 90 0.8× 39 956
Capucine Baldini France 16 686 1.0× 280 0.5× 140 0.9× 172 1.4× 50 0.5× 89 964
L.L. Siu Canada 10 833 1.2× 290 0.6× 248 1.6× 179 1.5× 95 0.9× 30 1.1k
Shaad E. Abdullah United States 16 573 0.8× 271 0.5× 168 1.1× 211 1.8× 81 0.8× 63 911
Arsela Prelaj Italy 18 677 1.0× 521 1.0× 169 1.1× 130 1.1× 86 0.8× 82 1.0k
Charlotte Domblides France 14 404 0.6× 236 0.5× 201 1.3× 205 1.7× 62 0.6× 45 734
P. Jacoulet France 13 577 0.8× 481 0.9× 147 1.0× 76 0.6× 103 1.0× 53 823
Monika Serke Germany 15 688 1.0× 758 1.5× 194 1.3× 38 0.3× 129 1.2× 71 1.1k
Jean Pierre Delord France 13 514 0.8× 185 0.4× 233 1.5× 90 0.8× 64 0.6× 20 792

Countries citing papers authored by Suchita Pakkala

Since Specialization
Citations

This map shows the geographic impact of Suchita Pakkala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suchita Pakkala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suchita Pakkala more than expected).

Fields of papers citing papers by Suchita Pakkala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suchita Pakkala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suchita Pakkala. The network helps show where Suchita Pakkala may publish in the future.

Co-authorship network of co-authors of Suchita Pakkala

This figure shows the co-authorship network connecting the top 25 collaborators of Suchita Pakkala. A scholar is included among the top collaborators of Suchita Pakkala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suchita Pakkala. Suchita Pakkala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Behera, Madhusmita, Conor Steuer, Yuan Liu, et al.. (2020). Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis. The Oncologist. 25(6). e964–e975. 12 indexed citations
3.
Pakkala, Suchita, Kristin Higgins, Zhengjia Chen, et al.. (2020). Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study. Journal for ImmunoTherapy of Cancer. 8(2). e001302–e001302. 53 indexed citations
4.
Tian, Sibo, Xinyan Zhang, Renjian Jiang, et al.. (2019). Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database. Clinical Lung Cancer. 20(6). 484–493.e6. 17 indexed citations
5.
Pakkala, Suchita & Taofeek K. Owonikoko. (2018). Immune checkpoint inhibitors in small cell lung cancer. Journal of Thoracic Disease. 10(S3). S460–S467. 37 indexed citations
6.
Pakkala, Suchita & Suresh S. Ramalingam. (2018). Personalized therapy for lung cancer: Striking a moving target. JCI Insight. 3(15). 107 indexed citations
7.
Pillai, Rathi N., Madhusmita Behera, Taofeek K. Owonikoko, et al.. (2017). OA03.06 Evaluation of Toxicity Profile of PD-1 versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S253–S254. 7 indexed citations
8.
Higgins, Kristin, Rathi N. Pillai, Zhengjia Chen, et al.. (2017). Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non–Small Cell Lung Cancer: A Phase I Study. Journal of Thoracic Oncology. 12(11). 1687–1695. 42 indexed citations
9.
Owonikoko, Taofeek K., Guojing Zhang, Hyun S. Kim, et al.. (2016). Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Journal of Translational Medicine. 14(1). 111–111. 73 indexed citations
10.
Patel, Sandip Pravin, Nathan A. Pennell, Suchita Pakkala, et al.. (2016). Phase 1b study of crizotinib in combination with pembrolizumab in patients (pts) with untreated ALK-positive (+) advanced non-small cell lung cancer (NSCLC). Annals of Oncology. 27. vi449–vi449. 2 indexed citations
11.
Pakkala, Suchita & Suresh S. Ramalingam. (2016). Adjuvant therapy for nonsmall cell lung cancer. Current Opinion in Oncology. 28(2). 150–158. 6 indexed citations
12.
Pakkala, Suchita & Suresh S. Ramalingam. (2016). Epidermal Growth Factor Receptor Mutated Advanced Non–Small Cell Lung Cancer. Hematology/Oncology Clinics of North America. 31(1). 83–99. 9 indexed citations
13.
Steuer, Conor, Madhusmita Behera, Yuan Liu, et al.. (2016). Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base. Clinical Lung Cancer. 18(3). 286–292. 66 indexed citations
14.
Steuer, Conor, Madhusmita Behera, Vinicius Ernani, et al.. (2016). Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non–Small-Cell Lung Cancer. JAMA Oncology. 3(8). 1120–1120. 75 indexed citations
15.
Steuer, Conor, Madhusmita Behera, Kristin Higgins, et al.. (2015). Comparison of concurrent use of carboplatin-Paclitaxel versus cisplatin-etoposide with thoracic radiation for stage III NSCLC patients: A systematic review.. Journal of Clinical Oncology. 33(15_suppl). 7536–7536. 5 indexed citations
16.
Arellano, Martha, Suchita Pakkala, Amelia Langston, et al.. (2012). Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer. 118(21). 5278–5282. 34 indexed citations
17.
Pakkala, Suchita, Zhengjia Chen, David Rimland, et al.. (2011). Human immunodeficiency virus‐associated lung cancer in the era of highly active antiretroviral therapy. Cancer. 118(1). 164–172. 26 indexed citations
18.
Pakkala, Suchita & Suresh S. Ramalingam. (2010). Lung Cancer in HIV-Positive Patients. Journal of Thoracic Oncology. 5(11). 1864–1871. 35 indexed citations
19.
Pakkala, Suchita & Suresh S. Ramalingam. (2009). Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling in Non–Small-Cell Lung Cancer Therapy. Clinical Lung Cancer. 10. S17–S23. 15 indexed citations
20.
Sand, Juhani, Suchita Pakkala, & Isto Nordback. (1997). Twenty to thirty year follow-up after cholecystectomy.. PubMed. 43(9). 534–7. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reyes Bernabé Breakdown of academic impact, for papers by Filippo Gustavo Dall’Olio Breakdown of academic impact, for papers by Capucine Baldini Breakdown of academic impact, for papers by L.L. Siu Breakdown of academic impact, for papers by Shaad E. Abdullah Breakdown of academic impact, for papers by Arsela Prelaj Breakdown of academic impact, for papers by Charlotte Domblides Breakdown of academic impact, for papers by P. Jacoulet Breakdown of academic impact, for papers by Monika Serke Breakdown of academic impact, for papers by Jean Pierre Delord
Rankless by CCL
2026